PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Hanley, Daniel F.
TI  - MISTIE II Trial: 365-Day Results Demonstrate Improved Outcomes and Cost Benefit
DP  - 2013 May 01
TA  - MD Conference Express
PG  - 17--18
VI  - 13
IP  - 1
4099  - http://mdc.sagepub.com/content/13/1/17.short
4100  - http://mdc.sagepub.com/content/13/1/17.full
AB  - This article presents results from the Minimally Invasive Surgery Plus tPA for Intracerebral Hemorrhage Evacuation trial [MISTIE; NCT00224770], which showed that catheter-based clot reduction plus tissue plasminogen activator (MIS + tPA) is safe and may reduce long-term disability after intracerebral hemorrhage.